source
- Blackstone Life Sciences and Boston Scientific launch $455 million partnership to develop next-generation heart pumpBlackstone Life Sciences has entered a collaboration with Boston Scientific, committing $455 million to co‑fund development of a next‑generation miniature heart pump system. The device, called the…
- AbbVie pays $100M upfront in $1.4B deal for Nxera's phase-1 IBD candidateAbbVie has agreed to pay $100 million upfront for the worldwide rights to Nxera's oral EP4 receptor agonist, designated NXE0033744, with the total deal value potentially reaching $1.4 billion throu…